Insiders Updates
ImmunityBio Inc [IBRX] Investment Guide: What You Need to Know
As this happened, Piper Sandler upgraded its ImmunityBio Inc [IBRX] rating to an Overweight from a a Neutral in a
Menu
As this happened, Piper Sandler upgraded its ImmunityBio Inc [IBRX] rating to an Overweight from a a Neutral in a
Taking this into account, H.C. Wainwright initiated its ImmunityBio Inc [IBRX] rating to a Buy in a research note published
Following these proceedings, H.C. Wainwright initiated its ImmunityBio Inc [IBRX] rating to a Buy in a research note published on
In the meantime, H.C. Wainwright initiated its ImmunityBio Inc [IBRX] rating to a Buy in a research note published on
In the meantime, H.C. Wainwright initiated its ImmunityBio Inc [IBRX] rating to a Buy in a research note published on
As this happened, H.C. Wainwright initiated its ImmunityBio Inc [IBRX] rating to a Buy in a research note published on